Last updated on August 2019

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease


Brief description of study

TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Clinical Study Identifier: NCT03251118

Find a site near you

Start Over

Louisiana Research Center, LLC

Shreveport, LA United States
5.03miles
  Connect »